{"id":"https://openalex.org/W1921471033","doi":"https://doi.org/10.1007/s10637-015-0285-8","title":"Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients","display_name":"Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-19","ids":{"openalex":"https://openalex.org/W1921471033","doi":"https://doi.org/10.1007/s10637-015-0285-8","mag":"1921471033","pmid":"https://pubmed.ncbi.nlm.nih.gov/26386973","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4648966"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-015-0285-8","doi":"https://doi.org/10.1007/s10637-015-0285-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10637-015-0285-8","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs10637-015-0285-8.pdf","source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1921471033"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007%2Fs10637-015-0285-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028531005","display_name":"Jara M. Baas","orcid":"https://orcid.org/0000-0002-5936-0014","observed_orcids":["https://orcid.org/0000-0002-5936-0014"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. M. Baas","raw_affiliation_strings":["Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. j.m.baas@lumc.nl","Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. j.m.baas@lumc.nl","institution_ids":["https://openalex.org/I2800006345"]},{"raw_affiliation_string":"Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060745655","display_name":"Lisanne L. Krens","orcid":"https://orcid.org/0000-0003-3842-9585","observed_orcids":["https://orcid.org/0000-0003-3842-9585"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. L. Krens","raw_affiliation_strings":["Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019680927","display_name":"Albert J. ten Tije","orcid":"https://orcid.org/0000-0001-5892-9515","observed_orcids":["https://orcid.org/0000-0001-5892-9515"]},"institutions":[{"id":"https://openalex.org/I4210105981","display_name":"Amphia Ziekenhuis","ror":"https://ror.org/01g21pa45","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210105981"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. J. ten Tije","raw_affiliation_strings":["Department of Clinical Oncology, Amphia Hospital, Langendijk 75, 4819 EV, Breda, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Amphia Hospital, Langendijk 75, 4819 EV, Breda, The Netherlands","institution_ids":["https://openalex.org/I4210105981"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031023319","display_name":"Frans Erdkamp","orcid":"https://orcid.org/0000-0002-4793-4666","observed_orcids":["https://orcid.org/0000-0002-4793-4666"]},"institutions":[{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Erdkamp","raw_affiliation_strings":["Department of Clinical Oncology, Orbis Medical Center, Dr. H. van der Hoffplein 1, 6162 BG, Sittard-Geleen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Orbis Medical Center, Dr. H. van der Hoffplein 1, 6162 BG, Sittard-Geleen, The Netherlands","institution_ids":["https://openalex.org/I4210133559"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033225491","display_name":"Tom van Wezel","orcid":"https://orcid.org/0000-0001-5773-7730","observed_orcids":["https://orcid.org/0000-0001-5773-7730"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. van Wezel","raw_affiliation_strings":["Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111971466","display_name":"Hans Morreau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Morreau","raw_affiliation_strings":["Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025935523","display_name":"Hans A. J. Gelderblom","orcid":"https://orcid.org/0000-0001-9270-8636","observed_orcids":["https://orcid.org/0000-0001-9270-8636"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Gelderblom","raw_affiliation_strings":["Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030957904","display_name":"Henk\u2010Jan Guchelaar","orcid":"https://orcid.org/0000-0002-7085-1383","observed_orcids":["https://orcid.org/0000-0002-7085-1383"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. J. Guchelaar","raw_affiliation_strings":["Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028531005"],"corresponding_institution_ids":["https://openalex.org/I2800006345"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":1.2968,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.80632188,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"33","issue":"6","first_page":"1242","last_page":"1247"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9300000071525574},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mevalonate-pathway","display_name":"mevalonate pathway","score":0.8399999737739563},{"id":"https://openalex.org/keywords/egfr-inhibitor-resistance","display_name":"EGFR inhibitor resistance","score":0.652999997138977},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5799999833106995},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.6940000057220459},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.7540000081062317}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9706645011901855},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9603028297424316},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7920849323272705},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7195987701416016},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.7099810838699341},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.6466522216796875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6082361936569214},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5968248844146729},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.5381492376327515},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5322504043579102},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37199509143829346},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3568427264690399},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.18249991536140442}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1007/s10637-015-0285-8","doi":"https://doi.org/10.1007/s10637-015-0285-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10637-015-0285-8","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs10637-015-0285-8.pdf","source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4648966","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4648966/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Invest New Drugs","raw_type":"Text"},{"id":"pmid:26386973","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26386973","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:alma.31UKB_LEU:9940750774402711","doi":null,"is_oa":false,"landing_page_url":"https://scholarlypublications.universiteitleiden.nl/handle/1887/107175","pdf_url":null,"source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:openaccess.leidenuniv.nl:1887/107175","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1887/107175","pdf_url":null,"source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"33","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:scholarlypublications.universiteitleiden.nl:item_2996578","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/1887/107175","pdf_url":null,"source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.802.2692","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.802.2692","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/77/dc/10637_2015_Article_285.PMC4648966.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s10637-015-0285-8","doi":"https://doi.org/10.1007/s10637-015-0285-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10637-015-0285-8","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs10637-015-0285-8.pdf","source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1921471033.pdf","grobid_xml":"https://content.openalex.org/works/W1921471033.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W12110721","https://openalex.org/W1604547439","https://openalex.org/W1963581413","https://openalex.org/W1978658336","https://openalex.org/W1987616570","https://openalex.org/W1997523827","https://openalex.org/W2029409133","https://openalex.org/W2037243061","https://openalex.org/W2039805638","https://openalex.org/W2045634223","https://openalex.org/W2048293465","https://openalex.org/W2049282019","https://openalex.org/W2049659810","https://openalex.org/W2072907003","https://openalex.org/W2075985960","https://openalex.org/W2097121246","https://openalex.org/W2097254028","https://openalex.org/W2100195364","https://openalex.org/W2103878083","https://openalex.org/W2106789440","https://openalex.org/W2115790682","https://openalex.org/W2119460950","https://openalex.org/W2121869934","https://openalex.org/W2125756326","https://openalex.org/W2125955619","https://openalex.org/W2130037036","https://openalex.org/W2134519717","https://openalex.org/W2140692703","https://openalex.org/W2141801755","https://openalex.org/W2145376550","https://openalex.org/W2147834058","https://openalex.org/W2155311724","https://openalex.org/W2409313750","https://openalex.org/W2409420104","https://openalex.org/W2418412985","https://openalex.org/W2421979645","https://openalex.org/W2976628266"],"related_works":["https://openalex.org/W4254102401","https://openalex.org/W2125756326","https://openalex.org/W1978658336","https://openalex.org/W2409313750","https://openalex.org/W2108637466","https://openalex.org/W2963461892","https://openalex.org/W1506589504","https://openalex.org/W2049594890"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Cetuximab":[1],"is":[2],"registered":[3],"for":[4],"use":[5],"in":[6,38,79,85,140,164,194,207],"colorectal":[7],"cancer":[8],"(CRC)":[9],"patients":[10,80,109,149,167,209],"with":[11,24,81,93,189],"RAS":[12],"wild-type":[13,142],"tumours":[14],"only.":[15],"Simvastatin":[16],"blocks":[17],"the":[18,25,34,52,68,73,106,118,156,177,183,195],"mevalonate":[19],"pathway":[20,37],"and":[21,70,96,111],"thereby":[22],"interferes":[23],"post-translational":[26],"modification":[27],"(prenylation)":[28],"of":[29,72,75,108,121,146,186],"KRAS.":[30],"We":[31],"hypothesize":[32],"that":[33,126,182],"activated":[35],"KRAS":[36,39,83,141,187,213],"mutant":[40],"tumors":[41,49],"can":[42],"be":[43],"inhibited":[44],"by":[45],"simvastatin":[46,76,190],"rendering":[47],"these":[48,165],"sensitive":[50],"to":[51,66,77,104,162,171,202,205],"EGFR":[53],"inhibitor":[54],"cetuximab.":[55,122],"METHODS:":[56],"A":[57],"Simon":[58],"two-stage,":[59],"single-arm,":[60],"phase":[61],"II":[62],"study":[63,179],"was":[64,103,125,130,191],"performed":[65],"test":[67,105],"efficacy":[69],"safety":[71],"addition":[74],"cetuximab":[78,206],"a":[82,211],"mutation":[84],"their":[86],"CRC":[87,208],"tumour":[88],"who":[89],"were":[90,151,199],"previously":[91],"treated":[92],"fluoropyrimidine,":[94],"oxaliplatin":[95],"irinotecan":[97],"based":[98],"regimens.":[99],"The":[100,160],"primary":[101,157],"endpoint":[102,158],"percentage":[107],"alive":[110],"free":[112,131,152],"from":[113,132,153,169],"progression":[114,154,163],"12.5":[115],"weeks":[116],"after":[117],"first":[119],"administration":[120],"Our":[123],"hypothesis":[124],"at":[127,155],"least":[128],"40%":[129],"progression,":[133],"comparable":[134],"to,":[135],"though":[136],"slightly":[137],"lower":[138],"than":[139],"patients.":[143],"RESULTS:":[144],"Four":[145],"18":[147],"included":[148],"(22.2%)":[150],"time.":[159],"time":[161],"4":[166],"ranged":[168],"20.3":[170],"47":[172],"weeks.":[173],"CONCLUSION:":[174],"Based":[175],"on":[176],"current":[178],"we":[180,198],"conclude":[181],"theoretical":[184],"concept":[185],"modulation":[188],"not":[192,200],"applicable":[193],"clinic,":[196],"as":[197],"able":[201],"restore":[203],"sensitivity":[204],"harbouring":[210],"somatic":[212],"mutation.":[214]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1921471033","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
